Topical chemoprevention of skin cancer with dual inhibitors of 5-LOX and COX-2 via a microemulsion system

被引：0
|
作者：
Feng, L. N. [1 ]
Mardirossian, V. [1 ]
Wang, Z. [1 ]
机构：
[1] Boston Univ, Sch Med, Boston, MA 02118 USA
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71230-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5513
引用
收藏
页码：328 / 328
页数：1
相关论文
共 50 条
  • [31] Treatment with either COX-2 inhibitor or 5-LOX inhibitor causes no compensation between COX-2 pathway and 5-LOX pathway in chronic aluminum overload-induced liver injury in rats
    Xia, Hui
    He, Qin
    Wang, Hong
    Wang, Yongming
    Yang, Yang
    Li, Yuke
    Zhang, Jiahua
    Chen, Zhihao
    Yang, Junqing
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 (05) : 535 - 543
  • [32] Psoralidin, a dual inhibitor of COX-2 and 5-LOX, regulates ionizing radiation (IR)-induced pulmonary inflammation
    Yang, Hee Jung
    Youn, HyeSook
    Seong, Ki Moon
    Yun, Young Ju
    Kim, Wanyeon
    Kim, Young Ha
    Lee, Ji Young
    Kim, Cha Soon
    Jin, Young-Woo
    Youn, BuHyun
    [J]. BIOCHEMICAL PHARMACOLOGY, 2011, 82 (05) : 524 - 534
  • [33] A novel class of tyrosine derivatives as dual 5-LOX and COX-2/mPGES1 inhibitors with PGE2 mediated anticancer properties
    Puratchikody, Ayarivan
    Umamaheswari, Appavoo
    Irfan, Navabshan
    Sinha, Shweta
    Manju, S. L.
    Ramanan, Meera
    Ramamoorthy, Gayathri
    Doble, Mukesh
    [J]. NEW JOURNAL OF CHEMISTRY, 2019, 43 (02) : 834 - 846
  • [34] The study of dual COX-2/5-LOX inhibitors by using electronic-topological approach based on data on the ligand-receptor interactions
    Aksakal, Fatma
    Shvets, Natali
    Dimoglo, Anatholy
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2015, 60 : 79 - 88
  • [35] Chemoprevention of colon and small intestinal tumorigenesis in ApcMin/+ mice by licofelone, a novel dual 5-LOX/COX inhibitor
    Mohammed, Altaf
    Qian, Li
    Janakiram, Naveena
    Choi, Chang-In
    Zhang, Yuting
    Steele, Vernon
    Rao, Chinthalapally
    [J]. CANCER RESEARCH, 2009, 69
  • [36] Towards safer anti-inflammatory therapy: synthesis of new thymol-pyrazole hybrids as dual COX-2/5-LOX inhibitors
    El-Miligy, Mostafa M. M.
    Al-Kubeisi, Ahmed K.
    Bekhit, Mohamed G.
    El-Zemity, Saad R.
    Nassra, Rasha A.
    Hazzaa, Aly A.
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2023, 38 (01) : 294 - 308
  • [37] In vitro COX-1, COX-2 and 5-LOX inhibitory activity of plant family Ranunculaceae
    Malik, J.
    Landa, P.
    Kutil, Z.
    Marsik, P.
    Kokoska, L.
    [J]. PLANTA MEDICA, 2011, 77 (12) : 1434 - 1435
  • [38] Discovery of COX-1 and 5-LOX dual inhibitors by UHPLC-HRFTMS-metabolomics
    Faleiro, D. P. V.
    Da Costa, F. B.
    [J]. PLANTA MEDICA, 2016, 82
  • [39] Dual COX-2/5-LOX inhibitors from Zanthoxylum simulans inhibit gastric cancer cells by cross-mediating thyroid, estrogen, and oxytocin signaling pathways
    Tian, Yong-Qiang
    Liu, Jing
    Cheng, Peng
    Zou, Jian
    Xu, Hui-Fang
    Shi, Xin-Hua
    Zhang, Yi-Sheng
    Mei, Ling
    [J]. FRONTIERS IN CHEMISTRY, 2024, 11
  • [40] The effects of hcy on the expression of cox-2 and 5-lox in experimental colitis rats model
    Wang, Jing
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 230 - 230
12345